Future Empire, a wholly-owned subsidiary of China Intelligent Health (00348), executed a series of transactions on the Stock Exchange on April 10, 2026, to divest 500,000 shares of Yunfeng. The total consideration for the sale amounted to approximately HK$1.56 million. The average selling price per Yunfeng share was about HK$3.13.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.